| Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity PL Bernard, R Delconte, S Pastor, V Laletin, CC Da Silva, A Goubard, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 44 | 2022 |
| Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets V Laletin, PL Bernard, CC da Silva, G Guittard, J Nunes Journal for Immunotherapy of Cancer 11 (5), e005845, 2023 | 10 | 2023 |
| High-throughput mass cytometry staining for deep phenotyping of human natural killer cells AB Amara, MS Rouviere, S Fattori, J Wlosik, E Gregori, N Boucherit, ... STAR protocols 3 (4), 101768, 2022 | 5 | 2022 |
| Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA C Delehedde, I Ciganek, PL Bernard, N Laroui, CC Da Silva, ... Molecular Therapy-Nucleic Acids 35 (3), 2024 | 2 | 2024 |
| DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing V Laletin, PL Bernard, C Montersino, Y Yamanashi, D Olive, R Castellano, ... Scientific Reports 14 (1), 15053, 2024 | 2 | 2024 |
| Unleashing NK cell signaling to improve cancer immunotherapy PL Bernard, V Laletin, S Pastor, JA Nunes, G Guittard Medecine sciences: M/S 36, 50-55, 2020 | 1* | 2020 |
